2Haring HU & Mehnert H. Pathogenesis of type 2(non - insulin -dependent)diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle. Diabetologia 1993 ;36:176 - 182. 被引量：1
3Bergstrom RW, Newell - Morris LL, Leonetti DL, et al. Association of elevated fasting C - peptide level and increased intra adbomihal fat distributin with development of NIDDM in Japanese - American men. Diabetes 1990; 39:104 - 111. 被引量：1
4Zisman A, Peroni OD, Abel ED, et al. Targeted disruption of the glucose transporter 4 selectvely in muscle causes insulin resistance and glucose intolerance. Nature Medicine 2000;6:924-928. 被引量：1
5Edelman SV. Type Ⅱ diabetes mellitus. Advances in internal medicine 1998;43:449-500. 被引量：1
6Kobayashi M. Effects of current therapeutic interventions on insulin resistance. Diabetes, Obesity & Metabolism 1999; 1: S32 -S40. 被引量：1
7Haffner SM. Epidemiolgy of insulin resistance and its relation to coronary artery disease. American Journal of Cardiology 1999; 84:11J - 14J. 被引量：1
8Young PW, Cawthorne MA, Coyle PJ, et al. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell - surface GLUT4 as measured by photoaffinity labeling. Diabetes 1995; 44:1087 - 1092. 被引量：1
9Miyazaki Y, Matsuda M, Mahankali A, et al. Mechanisms of glucose- lowering effect by rosiglitazone in patients with type 2 diabetes. Diabetes 2001;50(Supplement 2) :A126. 被引量：1
